Bihua Chen
Affiliations
- at Eyepoint Pharmaceuticals Inc. (EYPT), 2024-04-22
- at Immuneering Corp (IMRX), 2024-04-03
- at Corbus Pharmaceuticals Holdings Inc. (CRBP), 2024-03-11
- Ceo And Chairperson at Helix Acquisition Corp. Ii (HLXB), 2024-02-14
- at Ambrx Biopharma Inc. (AMAM), 2023-10-25
- at Moonlake Immunotherapeutics (MLTX), 2023-10-10
- at Ambrx Biopharma Inc. (AMAM), 2023-09-19
- at Greenlight Biosciences Holdings Pbc (GRNA), 2023-07-24
- at Erasca Inc. (ERAS), 2023-06-26
- at Biomea Fusion Inc. (BMEA), 2023-06-16
- Other at Vigil Neuroscience Inc. (VIGL), 2022-01-13
- Other at Ventyx Biosciences Inc. (VTYX), 2021-10-27
- Director, Other at Pyxis Oncology Inc. (PYXS), 2021-10-15
- Director, Other at Tyra Biosciences Inc. (TYRA), 2021-09-21
- Other at Icosavax Inc. (ICVX), 2021-08-04
- Other at Aerovate Therapeutics Inc. (AVTE), 2021-07-07
- Large Shareholder at Elevation Oncology Inc. (ELEV), 2021-06-24
- Large Shareholder, Director at Monte Rosa Therapeutics Inc. (GLUE), 2021-06-23
- Director at Verve Therapeutics Inc. (VERV), 2021-06-23
- Director at Rain Therapeutics Inc. (RAIN), 2021-04-29
- Director, Other at Design Therapeutics Inc. (DSGN), 2021-04-01
- Director, Other at Prometheus Biosciences Inc. (RXDX), 2021-03-18
- Large Shareholder, Director at Bioatla Inc. (BCAB), 2020-12-22
- Large Shareholder, Director at Olema Pharmaceuticals Inc. (OLMA), 2020-11-23
- Large Shareholder, Director at Atea Pharmaceuticals Inc. (AVIR), 2020-11-05
- Large Shareholder, Director at Akouos Inc. (AKUS), 2020-07-02
- Large Shareholder, Director at Avidity Biosciences Inc. (RNA), 2020-06-18
- Large Shareholder, Director at Turning Point Therapeutics Inc. (TPTX), 2019-08-12
- Large Shareholder, Director at Axonics Modulation Technologies Inc. (AXNX), 2018-11-02
- Large Shareholder, Director at Constellation Pharmaceuticals Inc (CNST), 2018-07-20
- Large Shareholder, Director at Kezar Life Sciences Inc. (KZR), 2018-06-27
- Large Shareholder, Director at Kiniksa Pharmaceuticals Ltd. (KNSA), 2018-05-31
- Large Shareholder, Director at Proteostasis Therapeutics Inc. (PTI), 2017-12-18
- Large Shareholder, Director at Apellis Pharmaceuticals Inc. (APLS), 2017-11-14
- Large Shareholder, Director at Clearside Biomedical Inc. (CLSD), 2016-06-13
- Large Shareholder, Director at Cellectar Biosciences Inc. (CLRB), 2014-09-05
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| HLXB | $10.00 | 903,600 | Large Shareholder, Officer, Director | 903,600 | 2024-02-13 | Filing | |
| HLXB | $10.00 | 1,427,040 | Large Shareholder, Officer, Director | 1,427,040 | 2024-02-13 | Filing | |
| HLXB | $10.00 | 69,360 | Large Shareholder, Officer, Director | 69,360 | 2024-02-13 | Filing | |
| MLTX | $59.90 | 58,839 | 8,494,151 | 2023-10-05 | Filing | ||
| MLTX | $57.32 | 67,814 | 8,435,312 | 2023-10-04 | Filing |
Insider Trading: Sales See All